Form 4 Tracker
Stoke Therapeutics, Inc.
STOK

42 insider filings · Latest: Oct 2, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Oct 2, 2026Oct 2 9:37 PMJonathan AllanGENERAL COUNSEL & CORP SEC
Sale
627$26.33$16.5K20,598(D)

View →

Oct 1, 2026Oct 2 9:35 PMBarry TichoCHIEF MEDICAL OFFICER
Sale
1,051$26.16$27.5K19,059(D)

View →

Oct 2, 2026Oct 2 8:20 PMJONATHAN D ALLAN
Proposed Sale
627$26.01$16.3K—

View →

Sep 1, 2026Sep 3 8:17 PMBarry TichoCHIEF MEDICAL OFFICER
Sale
5,545$30.67$170.1K20,110(D)

View →

Aug 18, 2026Aug 19 12:29 AMBarry TichoCHIEF MEDICAL OFFICER
Sale
4,767$32.03$152.7K25,655(D)

View →

Aug 18, 2026Aug 19 12:28 AMEdward M. Kaye MDDirector
Sale
12,567$32.03$402.5K124,557(D)

View →

Aug 18, 2026Aug 19 12:27 AMJonathan AllanGENERAL COUNSEL & CORP SEC
Sale
2,861$32.03$91.6K21,225(D)

View →

Aug 3, 2026Aug 5 8:17 PMBarry TichoCHIEF MEDICAL OFFICER
Sale
7,176$29.04$208.4K20,422(D)

View →

Aug 3, 2026Aug 3 8:48 PMBARUCH TICHO
Proposed Sale
20,967$28.86$605.1K—

View →

Jul 1, 2026Jul 6 8:10 PMBarry TichoCHIEF MEDICAL OFFICER
Sale
7,228$32.66$236.1K27,598(D)

View →

Jul 1, 2026Jul 1 8:51 PMBARUCH S. TICHO
Proposed Sale
7,228$32.72$236.5K—

View →

Jun 16, 2026Jun 18 8:18 PMJonathan AllanGENERAL COUNSEL & CORP SEC
Sale
1,457$29.95$43.6K18,086(D)

View →

Jun 16, 2026Jun 16 8:33 PMJONATHAN D ALLAN
Proposed Sale
1,457$30.00$43.7K—

View →

Jun 1, 2026Jun 3 9:33 PMBarry TichoCHIEF MEDICAL OFFICER
Sale
1,795$30.58$54.9K34,826(D)

View →

May 1, 2026May 5 8:18 PMBarry TichoCHIEF MEDICAL OFFICER
Sale
2,243$32.79$73.5K36,621(D)

View →

May 1, 2026May 1 8:44 PMBARUCH S. TICHO
Proposed Sale
4,038$32.72$132.1K—

View →

Apr 1, 2026Apr 3 8:12 PMBarry TichoCHIEF MEDICAL OFFICER
Sale
1,838$32.66$60.0K38,864(D)

View →

Apr 1, 2026Apr 1 8:39 PMBARUCH S. TICHO
Proposed Sale
1,838$32.56$59.8K—

View →

Mar 20, 2026Mar 24 8:19 PMJonathan AllanGENERAL COUNSEL & CORP SEC
Sale
9,293$33.69$313.0K19,543(D)

View →

Mar 20, 2026Mar 20 8:33 PMJONATHAN ALLAN
Proposed Sale
9,293$33.19$308.4K—

View →

Page 1 of 3

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 15, 2026Mar 17 9:23 PMJonathan AllanGENERAL COUNSEL & CORP SEC
Option Exercise
25,475—36,000(D)

View →

Mar 10, 2026Mar 12 8:57 PMArthur TzianabosDirector, Interim Executive Chair
Option Exercise
3,955$8.33118,696(D)

View →

Feb 17, 2026Feb 19 9:25 PMBarry TichoCHIEF MEDICAL OFFICER
Grant/Award
100,000$31.0940,000(D)

View →

Feb 17, 2026Feb 19 9:24 PMIan F SmithDirector, Chief Executive Officer
Grant/Award
322,000$31.09129,000(D)

View →

Feb 17, 2026Feb 19 9:22 PMThomas LeggettChief Financial Officer
Grant/Award
100,000$31.0940,000(D)

View →

Feb 17, 2026Feb 19 9:21 PMJason HoittChief Patient Officer
Grant/Award
120,000$31.0948,000(D)

View →

Feb 17, 2026Feb 19 9:20 PMJonathan AllanGENERAL COUNSEL & CORP SEC
Grant/Award
88,000$31.0935,000(D)

View →

← Previous

Page 2 of 2